HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The "genomic storm" induced by bacterial endotoxin is calmed by a nuclear transport modifier that attenuates localized and systemic inflammation.

Abstract
Lipopolysaccharide (LPS) is a potent microbial virulence factor that can trigger production of proinflammatory mediators involved in the pathogenesis of localized and systemic inflammation. Importantly, the role of nuclear transport of stress responsive transcription factors in this LPS-generated "genomic storm" remains largely undefined. We developed a new nuclear transport modifier (NTM) peptide, cell-penetrating cSN50.1, which targets nuclear transport shuttles importin α5 and importin β1, to analyze its effect in LPS-induced localized (acute lung injury) and systemic (lethal endotoxic shock) murine inflammation models. We analyzed a human genome database to match 46 genes that encode cytokines, chemokines and their receptors with transcription factors whose nuclear transport is known to be modulated by NTM. We then tested the effect of cSN50.1 peptide on proinflammatory gene expression in murine bone marrow-derived macrophages stimulated with LPS. This NTM suppressed a proinflammatory transcriptome of 37 out of 84 genes analyzed, without altering expression of housekeeping genes or being cytotoxic. Consistent with gene expression analysis in primary macrophages, plasma levels of 23 out of 26 LPS-induced proinflammatory cytokines, chemokines, and growth factors were significantly attenuated in a murine model of LPS-induced systemic inflammation (lethal endotoxic shock) while the anti-inflammatory cytokine, interleukin 10, was enhanced. This anti-inflammatory reprogramming of the endotoxin-induced genomic response was accompanied by complete protection against lethal endotoxic shock with prophylactic NTM treatment, and 75% protection when NTM was first administered after LPS exposure. In a murine model of localized lung inflammation caused by direct airway exposure to LPS, expression of cytokines and chemokines in the bronchoalveolar space was suppressed with a concomitant reduction of neutrophil trafficking. Thus, calming the LPS-triggered "genomic storm" by modulating nuclear transport with cSN50.1 peptide attenuates the systemic inflammatory response associated with lethal shock as well as localized lung inflammation.
AuthorsAntonio DiGiandomenico, Ruth Ann Veach, Jozef Zienkiewicz, Daniel J Moore, Lukasz S Wylezinski, Martha A Hutchens, Jacek Hawiger
JournalPloS one (PLoS One) Vol. 9 Issue 10 Pg. e110183 ( 2014) ISSN: 1932-6203 [Electronic] United States
PMID25329889 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Cell-Penetrating Peptides
  • Chemokines
  • Lipopolysaccharides
  • Transcription Factors
Topics
  • Active Transport, Cell Nucleus (drug effects)
  • Animals
  • Bone Marrow Cells (cytology)
  • Cell Nucleus (drug effects, metabolism)
  • Cell-Penetrating Peptides (pharmacology, therapeutic use)
  • Chemokines (blood)
  • Gene Expression Regulation (drug effects)
  • Genome, Human (drug effects, genetics)
  • Humans
  • Lipopolysaccharides (toxicity)
  • Macrophages (cytology, drug effects, metabolism)
  • Mice
  • Pneumonia (chemically induced, drug therapy, genetics, pathology)
  • Shock, Septic (chemically induced, drug therapy, genetics, pathology)
  • Transcription Factors (metabolism)
  • Transcriptome (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: